Evidence map›Paper›PMID 41469389›Full record

ArticleNature communications2025

Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1.

Paolo G Cocomazzi, Anastasia Iatrou, Claudia Minici, Maria Gounari, Alexandra Theresa Linder, Can Akpınaroğlu, Marco Patrone, Luca Broggini, Michela Frenquelli, Ioannis Sarrigeorgiou and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. IGLV3-21HemaSphere · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Paolo G Cocomazzi *Biocrystallography Unit, Department of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milano, Italy.ORCID http://orcid.org/0000-0003-4733-6428
Anastasia Iatrou *Institute of Applied Biosciences, Centre for Research and Technology, Thessaloniki, Greece.
Claudia Minici *Biocrystallography Unit, Department of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milano, Italy.ORCID http://orcid.org/0000-0002-8350-484X
Maria GounariInstitute of Applied Biosciences, Centre for Research and Technology, Thessaloniki, Greece.
Alexandra Theresa LinderInstitute of Immunology, University Hospital of Ulm, Ulm, Germany.
Can AkpınaroğluInstitute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-0206-1862
Marco PatroneBiocrystallography Unit, Department of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milano, Italy.ORCID http://orcid.org/0000-0002-5164-2877
Luca BrogginiDepartment of Biosciences, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0001-9472-6854
Michela FrenquelliB-cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID http://orcid.org/0000-0003-4166-0438
Ioannis SarrigeorgiouImmunology Laboratory, Immunology Department, Hellenic Pasteur Institute, Athens, Greece.ORCID http://orcid.org/0000-0002-3545-0330
Peggy LymberiImmunology Laboratory, Immunology Department, Hellenic Pasteur Institute, Athens, Greece.ORCID http://orcid.org/0000-0002-4693-789X
Georgios PetrakisPathology Department, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-8822-0141
Triantafyllia KoletsaPathology Department, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-4435-3532
Lydia ScarfòB-cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
Andreas AgathangelidisDepartment of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.ORCID http://orcid.org/0000-0002-8467-7945
Hassan JumaaInstitute of Immunology, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-3383-141X
Palash C MaityInstitute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-3295-5859
Paolo GhiaB-cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID http://orcid.org/0000-0003-3750-7342
Kostas StamatopoulosInstitute of Applied Biosciences, Centre for Research and Technology, Thessaloniki, Greece. kostas.stamatopoulos@certh.gr.ORCID http://orcid.org/0000-0001-8529-640X
Massimo DeganoBiocrystallography Unit, Department of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milano, Italy. degano.massimo@hsr.it.ORCID http://orcid.org/0000-0002-0787-1883

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG17032Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG25764Deutsche Forschungsgemeinschaft (German Research Foundation) CRC1279Fritz Thyssen Stiftung (Fritz Thyssen Foundation) 10.23.1.012MNMinistero della Salute (Ministry of Health, Italy) RF-2018-12368231Worldwide Cancer Research 19-0096
6 · The paper itself

Abstract

A shared feature of B-cell receptors (BCRs) expressed on neoplastic B cells from patients with chronic lymphocytic leukaemia (CLL) concerns their continual activation of intracellular signalling without requiring external antigens. This autonomous signalling mechanism has previously been demonstrated to arise from BCR-BCR homotypic interactions in three distinct stereotyped CLL subsets (2, 4 and 169). CLL subset 1 is the second largest stereotyped subset, epitomizing unmutated CLL and known for a particularly aggressive clinical course. Here we show that, despite their significant sequence similarity, BCRs originating from three different subset 1 CLL cases exhibit variations in their combining site structures and associated physicochemical properties. Subset 1 BCRs are characterized by a common reactivity pattern towards various autoantigens, though they maintain distinct receptor-specific characteristics. Analysis of crystal structures of the respective BCR Fab fragments reveals lack of conservation in intermolecular crystal contacts, paralleled by no self-association in solution and incapacity to induce intracellular signalling when expressed in a model B-cell line. These findings suggest that cell-autonomous signalling may not be universally present across all CLL, implying the existence of other mechanisms in sustaining leukemic cell proliferation and CLL progression mediated by BCR signalling.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellReceptors, Antigen, B-CellSignal TransductionAutoantigensB-LymphocytesCrystallography, X-RayHumansImmunoglobulin Fab FragmentsAutoantigensImmunoglobulin Fab FragmentsReceptors, Antigen, B-Cell

Identifiers

PMID41469389
PMCPMC12868647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.